[HTML][HTML] SARS-CoV-2 B. 1.617. 2 Delta variant replication and immune evasion
The B.1.617.2 (Delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
was first identified in the state of Maharashtra in late 2020 and spread throughout India, …
was first identified in the state of Maharashtra in late 2020 and spread throughout India, …
[HTML][HTML] Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
B Meng, A Abdullahi, IATM Ferreira, N Goonawardane… - Nature, 2022 - nature.com
The SARS-CoV-2 Omicron BA.1 variant emerged in 2021 1 and has multiple mutations in its
spike protein 2 . Here we show that the spike protein of Omicron has a higher affinity for …
spike protein 2 . Here we show that the spike protein of Omicron has a higher affinity for …
[HTML][HTML] Sensitivity of SARS-CoV-2 B. 1.1. 7 to mRNA vaccine-elicited antibodies
DA Collier, A De Marco, IATM Ferreira, B Meng… - Nature, 2021 - nature.com
Transmission of SARS-CoV-2 is uncontrolled in many parts of the world; control is compounded
in some areas by the higher transmission potential of the B.1.1.7 variant 1 , which has …
in some areas by the higher transmission potential of the B.1.1.7 variant 1 , which has …
[HTML][HTML] Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2
Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2,
there is little information about vaccine efficacy against variants of concern (VOC) in …
there is little information about vaccine efficacy against variants of concern (VOC) in …
[HTML][HTML] SARS-CoV-2 evolution during treatment of chronic infection
The spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
critical for virus infection through the engagement of the human ACE2 protein 1 and is a major …
critical for virus infection through the engagement of the human ACE2 protein 1 and is a major …
[PDF][PDF] Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7
We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike ΔH69/V70
in multiple independent lineages, often occurring after acquisition of receptor binding motif …
in multiple independent lineages, often occurring after acquisition of receptor binding motif …
SARS-CoV-2 B. 1.617 mutations L452R and E484Q are not synergistic for antibody evasion
The SARS-CoV-2 B.1.617 variant emerged in the Indian state of Maharashtra in late 2020.
There have been fears that 2 key mutations seen in the receptor-binding domain, L452R and …
There have been fears that 2 key mutations seen in the receptor-binding domain, L452R and …
[HTML][HTML] Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation
SARS-CoV-2 Spike protein is critical for virus infection via engagement of ACE2, and amino
acid variation in Spike is increasingly appreciated. Given both vaccines and therapeutics …
acid variation in Spike is increasingly appreciated. Given both vaccines and therapeutics …
[HTML][HTML] SARS-CoV-2 B. 1.1. 7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodies
DA Collier, A De Marco, IATM Ferreira, B Meng, R Datir… - MedRxiv, 2021 - ncbi.nlm.nih.gov
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) transmission is uncontrolled
in many parts of the world, compounded in some areas by higher transmission potential …
in many parts of the world, compounded in some areas by higher transmission potential …
[HTML][HTML] SARS-CoV-2 Omicron spike mediated immune escape, infectivity and cell-cell fusion
B Meng, IATM Ferreira, A Abdullahi, A Saito, I Kimura… - BioRxiv, 2021 - biorxiv.org
The SARS-CoV-2 Omicron BA.1 variant emerged in late 2021 and is characterised by
multiple spike mutations across all spike domains. Here we show that compared to the Delta …
multiple spike mutations across all spike domains. Here we show that compared to the Delta …